Valuation: Boston Scientific Corporation

Market Cap 64.7B 58.03B 53.04B 48.42B 91.22B 6,082B 94.09B 639B 255B 3,245B 243B 238B 10,246B P/E 2026 *
18.3x
P/E 2027 * 19.7x
Enterprise Value 75.19B 67.44B 61.63B 56.26B 106B 7,068B 109B 743B 296B 3,771B 282B 276B 11,906B EV / Sales 2026 *
3.59x
EV / Sales 2027 * 3.43x
Free-Float
82.48%
Yield 2026 *
-
Yield 2027 * -
11-03 Blackstone Life Sciences, Boston Scientific to Co-Fund Heart Pump MT
11-03 Blackstone, Boston Scientific Sign $455 Million Deal to Co-Fund Heart Pump DJ
11-03 Blackstone Life Sciences Announces Collaboration with Boston Scientific Corporation to Co-Fund Development of VITALYST Heart Pump CI
11-02 Boston Scientific Corporation Announces Positive Six-Month Primary Endpoint Results From SIMPLAAFY Randomized Controlled Trial of WATCHMAN FLX Pro Left Atrial Appendage Closure Device CI
10-31 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/TRANSEND/021/STRAIGHT/1RO/130; Material Number: M001195810 CI
10-31 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/SINGLE/027/STRAIGHT/1RO/130; Material Number: M001195410 CI
10-31 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/SINGLE/027/STRAIGHT/1RO/105; Material Number: M001195400 CI
10-31 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/SINGLE/027/BERN/1RO/105; Material Number: M001195430 CI
10-31 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/SINGLE/021/SWAN/1RO/155; Material Number: M001195310 CI
10-31 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/SINGLE/021/SWAN/1RO/105; Material Number: M001195290 CI
10-31 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/SINGLE/021/STRAIGHT/1RO/130; Material Number: M001195210 CI
10-31 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/SINGLE/021/STRAIGHT/1RO/105; Material Number: M001195200 CI
10-31 Boston Scientific Cork, Ltd and Boston Scientific Cork, Ltd. Recall Direxion Torqueable Microcatheter, NGMC/SINGLE/021/BERN/1RO/155; Material Number: M001195250 CI
1 day-4.23%
1 week+1.83%
Current month+1.83%
1 month+1.33%
3 months-13.29%
6 months-23.66%
Current year-55.17%
1 week 41.9
Extreme 41.9
46.97
1 month 39.57
Extreme 39.57
46.97
Current year 39.57
Extreme 39.57
100.9
1 year 39.57
Extreme 39.57
105.65
3 years 39.57
Extreme 39.57
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap. Importance
8/25/26 A Buy

Director

2,040 0.0001%
8/11/26 A Other

Controller/Auditor

2,930 0.0002%
8/10/26 A Other

Chief Financial Officer

9,908 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
-4.23%+1.83%-56.84%-19.05% 64.7B
+2.63%-0.32%+22.75%+52.69% 251B
-3.36%+4.81%-17.34%+63.31% 162B
+1.73%-0.85%+9.29%+17.76% 159B
+1.31%+11.01%+23.90%+52.22% 57.97B
-0.76%+4.13%+0.84%-6.12% 56.21B
-2.05%-2.95%+4.30%+54.85% 50.21B
+1.73%-0.06%+18.49%+62.52% 48.43B
+1.00%-1.11%+23.29%+81.48% 44.51B
-1.64%+7.59%+11.07%+15.88% 37.87B
Average -0.32%+1.67%+3.97%+37.55% 93.24B
Weighted average by Cap. +0.26%+0.58%+5.03%+40.53%

Financials

2026 *2027 *
Net sales 20.97B 18.81B 17.19B 15.69B 29.56B 1,971B 30.49B 207B 82.61B 1,052B 78.71B 77.02B 3,320B 21.03B 18.86B 17.24B 15.73B 29.64B 1,977B 30.58B 208B 82.84B 1,055B 78.92B 77.23B 3,329B
Net income 3.53B 3.17B 2.89B 2.64B 4.98B 332B 5.14B 34.89B 13.91B 177B 13.26B 12.97B 559B 3.24B 2.91B 2.66B 2.43B 4.57B 305B 4.71B 32.03B 12.77B 163B 12.17B 11.91B 513B
Net Debt 10.48B 9.4B 8.59B 7.85B 14.78B 986B 15.25B 104B 41.31B 526B 39.35B 38.51B 1,660B 7.39B 6.63B 6.06B 5.53B 10.42B 695B 10.74B 73B 29.11B 371B 27.73B 27.14B 1,170B
Projected Income Statement - Annual - Boston Scientific Corporation
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
07/11/26 $42.75 -4.23% 14,645,732
05/11/26 $44.64 -2.58% 22,492,478
04/11/26 $45.82 +5.33% 34,559,158
03/11/26 $43.50 -1.85% 18,889,704
02/11/26 $44.32 +5.57% 22,714,894
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Boston Scientific Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
44.64USD
Average target price
49.60USD
Spread / Average Target
+11.11%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Boston Scientific Corporation